TY  - GEN
AU  - Boni,C
AU  - Savoldi,L
AU  - Bisagni,G
AU  - Ceci,G
AU  - Crinò,L
AU  - De Lisi,V
AU  - Di Costanzo,F
AU  - Lasagni,L
AU  - Manenti,A L
AU  - Moretti,G
AU  - Rondini,E
AU  - Sassi,M
AU  - Zadro,A
TI  - Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
SN  - 0959-8049
PY  - 1999///0225
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cisplatin
KW  - administration & dosage
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mitomycins
KW  - Prospective Studies
KW  - Vindesine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/s0959-8049(98)00231-7
ER  -